Related Experiment Videos
Intrapulmonary distribution of deposited particles
P Brand1, K Häussinger, T Meyer
1Clinical Research Group Aerosols in Medicine, GSF Institute for Inhalation Biology, Gauting, Germany.
Summary
Understanding lung drug deposition is key for effective inhalation therapy. Particle size significantly impacts where inhaled drugs deposit, with larger particles concentrating in upper airways.
Area of Science:
- Pulmonary medicine
- Pharmacokinetics
- Biomedical engineering
Background:
- Inhalation drug delivery offers advantages over other routes for topical and systemic treatments.
- Targeted drug deposition within the bronchial tree or respiratory zone is crucial for effective inhalation therapy.
- Current methods lack precise individual assessment of drug deposition sites within the lungs.
Purpose of the Study:
- To introduce a novel method for estimating the longitudinal distribution of deposited particles in individual human lungs.
- To assess the influence of particle size, airflow rate, and tidal volume on drug deposition patterns.
- To provide a non-invasive tool for optimizing inhalation drug delivery strategies.
Main Methods:
- Photometric measurement of di-2-ethylhexyl sebacate (DEHS) droplet deposition in four healthy volunteers.
- Assessment of particle deposition distribution across varying airflow rates, tidal volumes (VTs), and particle sizes.
- Analysis of longitudinal particle distribution within specific lung volume elements.
Main Results:
- Significant inter-subject variability in longitudinal particle deposition patterns was observed.
- Particle deposition site is strongly dependent on particle size, shifting proximally with increasing diameter.
- Particles >5 microns rarely penetrate beyond 600 cm3 lung volume, irrespective of VT.
- Increased airflow rate slightly shifts deposition peripherally; tidal volume has a minor effect.
Conclusions:
- The developed method enables non-invasive investigation of individual lung drug deposition patterns.
- Particle size is the dominant factor influencing deposition site, guiding inhalation therapy design.
- This technique can optimize inhaled drug formulation and delivery strategies for targeted lung treatments.